277 related articles for article (PubMed ID: 31141912)
1. Omega 3-DHA and Delta-Tocotrienol Modulate Lipid Droplet Biogenesis and Lipophagy in Breast Cancer Cells: the Impact in Cancer Aggressiveness.
Pizato N; Kiffer LFMV; Luzete BC; Assumpção JAF; Correa LH; Melo HAB; Sant'Ana LP; Ito MK; Magalhães KG
Nutrients; 2019 May; 11(6):. PubMed ID: 31141912
[TBL] [Abstract][Full Text] [Related]
2. The blockade of lipophagy pathway is necessary for docosahexaenoic acid to regulate lipid droplet turnover in hepatic stellate cells.
Qiu S; Xu H; Lin Z; Liu F; Tan F
Biomed Pharmacother; 2019 Jan; 109():1841-1850. PubMed ID: 30551439
[TBL] [Abstract][Full Text] [Related]
3. Elimination of ALDH+ breast tumor initiating cells by docosahexanoic acid and/or gamma tocotrienol through SHP-1 inhibition of Stat3 signaling.
Xiong A; Yu W; Liu Y; Sanders BG; Kline K
Mol Carcinog; 2016 May; 55(5):420-30. PubMed ID: 25648304
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of lovastatin- and docosahexaenoic acid-initiated autophagy in triple negative breast cancer reverted resistance and enhanced cytotoxicity.
El-Ashmawy NE; Al-Ashmawy GM; Amr EA; Khedr EG
Life Sci; 2020 Oct; 259():118212. PubMed ID: 32768581
[TBL] [Abstract][Full Text] [Related]
5. Docosahexaenoic acid suppresses migration of triple-negative breast cancer cell through targeting metastasis-related genes and microRNA under normoxic and hypoxic conditions.
Javadian M; Shekari N; Soltani-Zangbar MS; Mohammadi A; Mansoori B; Maralbashi S; Shanehbandi D; Baradaran B; Darabi M; Kazemi T
J Cell Biochem; 2020 Mar; 121(3):2416-2427. PubMed ID: 31713924
[TBL] [Abstract][Full Text] [Related]
6. Omega-3 docosahexaenoic acid induces pyroptosis cell death in triple-negative breast cancer cells.
Pizato N; Luzete BC; Kiffer LFMV; Corrêa LH; de Oliveira Santos I; Assumpção JAF; Ito MK; Magalhães KG
Sci Rep; 2018 Jan; 8(1):1952. PubMed ID: 29386662
[TBL] [Abstract][Full Text] [Related]
7. Phloridzin docosahexaenoate, a novel fatty acid ester of a plant polyphenol, inhibits mammary carcinoma cell metastasis.
Fernando W; Coyle K; Marcato P; Vasantha Rupasinghe HP; Hoskin DW
Cancer Lett; 2019 Nov; 465():68-81. PubMed ID: 31473253
[TBL] [Abstract][Full Text] [Related]
8. Oxidized derivative of docosahexaenoic acid preferentially inhibit cell proliferation in triple negative over luminal breast cancer cells.
Pogash TJ; El-Bayoumy K; Amin S; Gowda K; de Cicco RL; Barton M; Su Y; Russo IH; Himmelberger JA; Slifker M; Manni A; Russo J
In Vitro Cell Dev Biol Anim; 2015 Feb; 51(2):121-7. PubMed ID: 25413005
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of omega-3 fatty acid-induced growth inhibition in MDA-MB-231 human breast cancer cells.
Schley PD; Jijon HB; Robinson LE; Field CJ
Breast Cancer Res Treat; 2005 Jul; 92(2):187-95. PubMed ID: 15986129
[TBL] [Abstract][Full Text] [Related]
10. Tocotrienols Modulate Breast Cancer Secretomes and Affect Cancer-Signaling Pathways in MDA-MB-231 Cells: A Label-Free Quantitative Proteomic Analysis.
Ramdas P; Radhakrishnan AK; Abdu Sani AA; Abdul-Rahman PS
Nutr Cancer; 2019; 71(8):1263-1271. PubMed ID: 31084432
[TBL] [Abstract][Full Text] [Related]
11. Differential sensitization of cancer cells to doxorubicin by DHA: a role for lipoperoxidation.
Mahéo K; Vibet S; Steghens JP; Dartigeas C; Lehman M; Bougnoux P; Goré J
Free Radic Biol Med; 2005 Sep; 39(6):742-51. PubMed ID: 16109304
[TBL] [Abstract][Full Text] [Related]
12. Lipophagy and prostate cancer: association with disease aggressiveness and proximity to periprostatic adipose tissue.
Fontaine A; Bellanger D; Guibon R; Bruyère F; Brisson L; Fromont G
J Pathol; 2021 Oct; 255(2):166-176. PubMed ID: 34219239
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial-dependent anticancer activity of δ-tocotrienol and its synthetic derivatives in HER-2/neu overexpressing breast adenocarcinoma cells.
Viola V; Ciffolilli S; Legnaioli S; Piroddi M; Betti M; Mazzini F; Pierpaoli E; Provinciali M; Galli F
Biofactors; 2013; 39(4):485-93. PubMed ID: 23361894
[TBL] [Abstract][Full Text] [Related]
14. Exogenous supplementation with omega-3 polyunsaturated fatty acid docosahexaenoic acid (DHA; 22:6n-3) synergistically enhances taxane cytotoxicity and downregulates Her-2/neu (c-erbB-2) oncogene expression in human breast cancer cells.
Menendez JA; Lupu R; Colomer R
Eur J Cancer Prev; 2005 Jun; 14(3):263-70. PubMed ID: 15901996
[TBL] [Abstract][Full Text] [Related]
15. Docosahexanoic acid improves chemotherapy efficacy by inducing CD95 translocation to lipid rafts in ER(-) breast cancer cells.
Ewaschuk JB; Newell M; Field CJ
Lipids; 2012 Nov; 47(11):1019-30. PubMed ID: 23054549
[TBL] [Abstract][Full Text] [Related]
16. Distinct roles of different forms of vitamin E in DHA-induced apoptosis in triple-negative breast cancer cells.
Xiong A; Yu W; Tiwary R; Sanders BG; Kline K
Mol Nutr Food Res; 2012 Jun; 56(6):923-34. PubMed ID: 22707267
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic targeting of PFKFB3 with a novel glycolytic inhibitor PFK158 promotes lipophagy and chemosensitivity in gynecologic cancers.
Mondal S; Roy D; Sarkar Bhattacharya S; Jin L; Jung D; Zhang S; Kalogera E; Staub J; Wang Y; Xuyang W; Khurana A; Chien J; Telang S; Chesney J; Tapolsky G; Petras D; Shridhar V
Int J Cancer; 2019 Jan; 144(1):178-189. PubMed ID: 30226266
[TBL] [Abstract][Full Text] [Related]
18. CDCP1 drives triple-negative breast cancer metastasis through reduction of lipid-droplet abundance and stimulation of fatty acid oxidation.
Wright HJ; Hou J; Xu B; Cortez M; Potma EO; Tromberg BJ; Razorenova OV
Proc Natl Acad Sci U S A; 2017 Aug; 114(32):E6556-E6565. PubMed ID: 28739932
[TBL] [Abstract][Full Text] [Related]
19. Docosahexaenoic acid inhibits the invasion of MDA-MB-231 breast cancer cells through upregulation of cytokeratin-1.
Blanckaert V; Kerviel V; Lépinay A; Joubert-Durigneux V; Hondermarck H; Chénais B
Int J Oncol; 2015; 46(6):2649-55. PubMed ID: 25825023
[TBL] [Abstract][Full Text] [Related]
20. Tumor anti-angiogenic effect and mechanism of action of delta-tocotrienol.
Shibata A; Nakagawa K; Sookwong P; Tsuzuki T; Oikawa S; Miyazawa T
Biochem Pharmacol; 2008 Aug; 76(3):330-9. PubMed ID: 18599020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
